Pancreatic Cancer — Trials, FDA Actions & Pivotal Research
14 updates aggregated from openFDA and ClinicalTrials.gov, covering trial milestones, FDA actions, and pivotal publications about Pancreatic Cancer.
Synced daily from openFDA and ClinicalTrials.gov. Last sync: .
Drugs with Pancreatic Cancer trials
Recruiting trials by city
Cities where Pancreatic Cancer trials in our archive had recruiting sites. Each link lists every currently recruiting paid clinical trial at that location.
Updates
2026
- Results postedNivolumab Combination Therapy Safety Results Posted for Pancreatic Cancer· May 11, 2026· drug: Nivolumab
- Results postedPancreatic Cancer: Trial Results Post Survival Data by Tissue microRNA· Apr 16, 2026
- Results postedPembrolizumab/NT-I7 Combination Shows Dose-Dependent TEAEs in Solid Tumors· Feb 9, 2026· drug: Pembrolizumab
- Results postedPembrolizumab Combination Trial for Resectable Pancreatic Cancer Shows No…· Feb 4, 2026· drug: Pembrolizumab
- Results postedKeytruda/TAK-500 Solid Tumor Study Terminated, Adverse Event Data Posted· Jan 22, 2026· drug: Pembrolizumab
- Results postedPancreatic Cancer: Adjunctive Therapies Show Reduced Chemo Neuropathy· Jan 21, 2026
2025
- Primary completionPancreatic Cancer: Liquid Biopsy Trial Reaches Primary Completion· Dec 31, 2025
- Results postedHOPE-Genomics Trial Results Posted for Cancer Patient Education· Dec 11, 2025
- Results postedAtezolizumab Combinations Show Varied ORR in Metastatic Pancreatic Cancer· Nov 21, 2025· drug: Atezolizumab
- Results postedPembrolizumab + Cabozantinib Phase 2 Trial: 1 Partial Response in Metastatic…· Nov 19, 2025· drug: Pembrolizumab
- Results postedPembrolizumab/Lenvatinib Combo Shows Up to 77.4% DCR in Ovarian Cancer· Nov 17, 2025· drug: Pembrolizumab
- Results postedNivolumab Combination Trial Posts Adverse Event Data in Solid Tumors· Oct 9, 2025· drug: Nivolumab
- Results postedPancreatic Cancer: SBRT Maximum Tolerated Dose Determined at 50 Gray· Sep 12, 2025
- Results postedPancreatic Cancer: SBRT Phase 1/2 Trial Posts 45 Gy Maximum Tolerated Dose· Jul 18, 2025